These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8989245)

  • 1. Abdominal fat determines growth hormone-binding protein levels in healthy nonobese adults.
    Fisker S; Vahl N; Jørgensen JO; Christiansen JS; Orskov H
    J Clin Endocrinol Metab; 1997 Jan; 82(1):123-8. PubMed ID: 8989245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone (GH) substitution for one year normalizes elevated GH-binding protein levels in GH-deficient adults secondary to a reduction in body fat. A placebo-controlled trial.
    Fisker S; Vahl N; Hansen TB; Jørgensen JO; Hagen C; Orskov H; Christiansen JS
    Growth Horm IGF Res; 1998 Apr; 8(2):105-12. PubMed ID: 10987677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults.
    Vahl N; Jørgensen JO; Jurik AG; Christiansen JS
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2209-15. PubMed ID: 8964853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body composition and circulating levels of insulin, insulin-like growth factor-binding protein-1 and growth hormone (GH)-binding protein affect the pharmacokinetics of GH in adults independently of age.
    Hansen TK; Jørgensen JO; Christiansen JS
    J Clin Endocrinol Metab; 2002 May; 87(5):2185-93. PubMed ID: 11994362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood growth hormone-binding protein levels in premenopausal and postmenopausal women: roles of body weight and estrogen levels.
    Bondanelli M; Margutti A; Ambrosio MR; Plaino L; Cobellis L; Petraglia F; degli Uberti EC
    J Clin Endocrinol Metab; 2001 May; 86(5):1973-80. PubMed ID: 11344194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone binding protein correlates strongly with leptin and percentage body fat in GH-deficient adults, is increased by GH replacement but does not predict IGF-I response.
    Florkowski CM; Barnard R; Livesey JH; Veveris T; Espiner EA; Donald RA
    Growth Horm IGF Res; 1999 Feb; 9(1):35-40. PubMed ID: 10207506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral adipose tissue is associated with circulating high affinity growth hormone-binding protein.
    Roelen CA; Koppeschaar HP; de Vries WR; Snel YE; Doerga ME; Zelissen PM; Thijssen JH; Blankenstein MA
    J Clin Endocrinol Metab; 1997 Mar; 82(3):760-4. PubMed ID: 9062478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year.
    Fisker S; Vahl N; Hansen TB; Jørgensen JO; Hagen C; Orskov H; Christiansen JS
    Metabolism; 1997 Jul; 46(7):812-7. PubMed ID: 9225837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity.
    Gleeson HK; Lissett CA; Shalet SM
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1061-7. PubMed ID: 15522943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults.
    Vahl N; Jørgensen JO; Skjaerbaek C; Veldhuis JD; Orskov H; Christiansen JS
    Am J Physiol; 1997 Jun; 272(6 Pt 1):E1108-16. PubMed ID: 9227458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender.
    Johannsson G; Bjarnason R; Bramnert M; Carlsson LM; Degerblad M; Manhem P; Rośen T; Thorén M; Bengtsson BA
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1575-81. PubMed ID: 8636370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.
    Doehner W; Pflaum CD; Rauchhaus M; Godsland IF; Egerer K; Cicoira M; Florea VG; Sharma R; Bolger AP; Coats AJ; Anker SD; Strasburger CJ
    Eur J Endocrinol; 2001 Dec; 145(6):727-35. PubMed ID: 11720897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced concentration of serum growth hormone (GH)-binding protein in children with chronic renal failure: correlation with GH insensitivity. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Tönshoff B; Cronin MJ; Reichert M; Haffner D; Wingen AM; Blum WF; Mehls O
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1007-13. PubMed ID: 9100565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrelationships of spontaneous growth hormone axis activity, body fat, and serum lipids in healthy elderly women and men.
    O'Connor KG; Harman SM; Stevens TE; Jayme JJ; Bellantoni MF; Busby-Whitehead MJ; Christmas C; Münzer T; Tobin JD; Roy TA; Cottrell E; St Clair C; Pabst KM; Blackman MR
    Metabolism; 1999 Nov; 48(11):1424-31. PubMed ID: 10582552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of growth hormone secretion on body composition in patients with Crohn's disease.
    Katznelson L; Fairfield WP; Zeizafoun N; Sands BE; Peppercorn MA; Rosenthal DI; Klibanski A
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5468-72. PubMed ID: 14602791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors.
    Clasey JL; Weltman A; Patrie J; Weltman JY; Pezzoli S; Bouchard C; Thorner MO; Hartman ML
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3845-52. PubMed ID: 11502822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body fat mass is a strong and negative predictor of peak stimulated growth hormone and bone mineral density in healthy adolescents during transition period.
    Perotti M; Perra S; Saluzzi A; Grassi G; Pincelli AI
    Horm Metab Res; 2013 Sep; 45(10):748-53. PubMed ID: 23913118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.